Insights Into a Naturally Occurring Glaucoma Model
About the Research Project
Program
Award Type
Standard
Award Amount
$197,696
Active Dates
March 01, 2021 - February 28, 2024
Grant ID
G2020047
Co-Principal Investigator(s)
James Higham, PhD, University of Calgary
Goals
By leveraging access to a large, existing sample of fresh eye tissues, we examine genes expressed, their sequences, and the metabolites that are present in individuals with and without naturally-occurring glaucoma in a closely related animal model. These data are essentially impossible to obtain for humans and provide a direct way to probe the biological functions that are impacted by glaucoma, along with genetic risk factors. These data have large promise to guide genetic screening panels used in diagnosis and prognosis of glaucoma in humans, and to identify molecules in our blood that can be used for early detection and treatment.
Summary
The goal of our project is to understand genetic and metabolic differences in ocular tissues of individuals with and without naturally occurring open-angle glaucoma (OAG) and ocular hypertension (OHT) to improve our understanding of the causes and consequences of these diseases. Our first specific aim is diagnose OAG and OHT in an animal model. We are using a comprehensive, multiplatform approach that combines the latest imaging technologies with traditional ocular exams. Our second aim is to identify gene expression and metabolite profiles associated with OAG and OHT. We are conducting a transcriptomic (RNA-sequencing) and metabolomic study of glaucoma-relevant ocular tissues from a subset of individuals with OAG/OHT and from closely related individuals with health visual systems. For genes and metabolites associated with disease, we will examine the linked biological pathways relevant for cell death and inflammation; pathways implicated in human glaucoma, a leading cause of blindness globally. To our knowledge, we are the first to unite OAG status with the transcriptomics and metabolomics of affected ocular tissues originating from the same samples. Furthermore, we accomplish this in an exceptional animal model with naturally occurring disease. Our research will provide new foundational knowledge concerning the biology and pathophysiology of glaucoma, essential data for understanding this diverse and multifaceted disease. With this information, we hope to improve early diagnostic tools, and identify druggable targets for disease treatments.
Grants
Related Grants
National Glaucoma Research
Saving Sight: A Journey to Healing Without Scars
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Jennifer Fan Gaskin, FRANZCO
Saving Sight: A Journey to Healing Without Scars
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Jennifer Fan Gaskin, FRANZCO
National Glaucoma Research
Retinal Ganglion Cell Axon Degeneration in a 3D Microfluidic Hydrogel Model
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Shruti Patil, PhD
Retinal Ganglion Cell Axon Degeneration in a 3D Microfluidic Hydrogel Model
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Shruti Patil, PhD
National Glaucoma Research
Harnessing Artificial Intelligence to Improve Glaucoma Clinical Trials
Active Dates
July 01, 2023 - June 30, 2025
Principal Investigator
Jithin Yohannan, MD, MPH
Harnessing Artificial Intelligence to Improve Glaucoma Clinical Trials
Active Dates
July 01, 2023 - June 30, 2025
Principal Investigator
Jithin Yohannan, MD, MPH